Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 64801 - 64825 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	BAX	581	upregulated	resveratrol results in increased expression of BAX mRNA	19q13.33	A23865 A23866 A22435
Resveratrol	Investigational	BBC3	27113	upregulated	resveratrol results in increased expression of BBC3 mRNA	19q13.32	A23867
Resveratrol	Investigational	BCAP31	10134	upregulated	resveratrol results in increased expression of BCAP31 mRNA	Xq28	A22289
Resveratrol	Investigational	BCHE	590	upregulated	resveratrol results in increased expression of BCHE mRNA	3q26.1	A21310
Resveratrol	Investigational	BCL2	596	downregulated	resveratrol results in decreased expression of BCL2 mRNA	18q21.33	A23865 A23844 A23866 A23868 A23869 A23870 A22435 A23871
Resveratrol	Investigational	BCL2	596	upregulated	resveratrol results in increased expression of BCL2 mRNA	18q21.33	A23872 A23873 A23874
Resveratrol	Investigational	BCL2A1	597	upregulated	resveratrol results in increased expression of BCL2A1 mRNA	15q25.1	A23852
Resveratrol	Investigational	BCL2L1	598	downregulated	resveratrol results in decreased expression of BCL2L1 mRNA	20q11.21	A23875 A23876 A23871
Resveratrol	Investigational	BCL2L1	598	upregulated	resveratrol results in increased expression of BCL2L1 mRNA	20q11.21	A23847 A23858
Resveratrol	Investigational	BCL2L2	599	upregulated	resveratrol results in increased expression of BCL2L2 mRNA	14q11.2	A23877 A23878
Resveratrol	Investigational	BCL6	604	upregulated	resveratrol results in increased expression of BCL6 mRNA	3q27.3	A22498 A23847
Resveratrol	Investigational	BDKRB2	624	downregulated	resveratrol results in decreased expression of BDKRB2 mRNA	14q32.2	A23858
Resveratrol	Investigational	BECN1	8678	upregulated	resveratrol results in increased expression of BECN1 mRNA	17q21.31	A23862
Resveratrol	Investigational	BGLAP	632	upregulated	resveratrol results in increased expression of BGLAP mRNA	1q22	A22321 A21151 A23879 A23880
Resveratrol	Investigational	BIRC2	329	upregulated	resveratrol results in increased expression of BIRC2 mRNA	11q22.2	A23847
Resveratrol	Investigational	BIRC5	332	downregulated	resveratrol results in decreased expression of BIRC5 mRNA	17q25.3	A23872 A21565 A23873 A23881 A23882 A23870 A23883
Resveratrol	Investigational	BIRC5	332	upregulated	resveratrol results in increased expression of BIRC5 mRNA	17q25.3	A23874
Resveratrol	Investigational	BMP2	650	upregulated	resveratrol results in increased expression of BMP2 mRNA	20p12.3	A23884
Resveratrol	Investigational	BMP4	652	upregulated	resveratrol results in increased expression of BMP4 mRNA	14q22.2	A23852
Resveratrol	Investigational	BMP6	654	downregulated	resveratrol results in decreased expression of BMP6 mRNA	6p24.3	A22498
Resveratrol	Investigational	BNIP1	662	upregulated	resveratrol results in increased expression of BNIP1 mRNA	5q35.1	A22289
Resveratrol	Investigational	BNIP2	663	upregulated	resveratrol results in increased expression of BNIP2 mRNA	15q22.2	A23847
Resveratrol	Investigational	BOK	666	upregulated	resveratrol results in increased expression of BOK mRNA	2q37.3	A23857
Resveratrol	Investigational	BRCA1	672	upregulated	resveratrol results in increased expression of BRCA1 mRNA	17q21.31	A23885
Resveratrol	Investigational	BRCA2	675	downregulated	resveratrol results in decreased expression of BRCA2 mRNA	13q13.1	A23854

Displaying entries 64801 - 64825 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability